EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park(University of California San Diego), Seung Kew Yoon(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 116
Related Papers
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385
Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
|PLoS ONE|2013|47
Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
|Pharmaceutics|2021|42
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
|Scientific Reports|2017|39
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
|International Journal of Molecular Sciences|2021|38